Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | UTHR |
---|---|---|
09:32 ET | 9112 | 264.39 |
09:34 ET | 800 | 264.407 |
09:36 ET | 1880 | 264.73 |
09:38 ET | 1518 | 264.36 |
09:39 ET | 1674 | 264.07 |
09:41 ET | 500 | 263.74 |
09:43 ET | 100 | 263.485 |
09:45 ET | 1705 | 262.15 |
09:48 ET | 100 | 261.92 |
09:50 ET | 667 | 261.48 |
09:52 ET | 1004 | 261.445 |
09:54 ET | 500 | 261.7 |
09:56 ET | 300 | 261.635 |
09:57 ET | 1329 | 261.24 |
09:59 ET | 1600 | 260.2 |
10:01 ET | 100 | 259.6 |
10:03 ET | 721 | 259.85 |
10:06 ET | 200 | 260.015 |
10:08 ET | 1300 | 260.91 |
10:10 ET | 500 | 260.98 |
10:12 ET | 100 | 260.98 |
10:14 ET | 4603 | 260.56 |
10:15 ET | 855 | 260.25 |
10:17 ET | 4145 | 259.34 |
10:19 ET | 100 | 259.1 |
10:21 ET | 100 | 258.79 |
10:24 ET | 1702 | 259.195 |
10:26 ET | 821 | 259.11 |
10:28 ET | 2033 | 258.395 |
10:30 ET | 100 | 258.2 |
10:32 ET | 349 | 257.88 |
10:33 ET | 200 | 257.63 |
10:35 ET | 100 | 257.965 |
10:37 ET | 1707 | 257.82 |
10:39 ET | 1000 | 257.78 |
10:42 ET | 917 | 257.4962 |
10:44 ET | 3503 | 257.95 |
10:46 ET | 1799 | 257.48 |
10:48 ET | 3501 | 257.5 |
10:50 ET | 1756 | 257.94 |
10:51 ET | 430 | 257.6301 |
10:53 ET | 7162 | 257.435 |
10:55 ET | 2194 | 257.5 |
10:57 ET | 5453 | 257.46 |
11:02 ET | 2411 | 257.54 |
11:04 ET | 200 | 257.5 |
11:06 ET | 500 | 257.34 |
11:08 ET | 400 | 257.07 |
11:09 ET | 100 | 257.3499 |
11:11 ET | 18993 | 256.44 |
11:13 ET | 4249 | 256.46 |
11:15 ET | 200 | 256.375 |
11:18 ET | 1600 | 256.73 |
11:20 ET | 200 | 256.72 |
11:22 ET | 2718 | 256.975 |
11:24 ET | 3697 | 257.695 |
11:26 ET | 1057 | 257.32 |
11:27 ET | 1196 | 257.145 |
11:29 ET | 2318 | 258.26 |
11:33 ET | 1300 | 258.015 |
11:36 ET | 870 | 258.325 |
11:38 ET | 200 | 258.07 |
11:40 ET | 3100 | 258.39 |
11:42 ET | 266 | 258.54 |
11:45 ET | 500 | 258.48 |
11:47 ET | 400 | 258.63 |
11:49 ET | 600 | 258.835 |
11:51 ET | 699 | 258.995 |
11:54 ET | 395 | 258.68 |
11:56 ET | 103 | 258.84 |
11:58 ET | 555 | 258.8112 |
12:00 ET | 1750 | 258.735 |
12:02 ET | 1140 | 258.31 |
12:05 ET | 500 | 258.4 |
12:07 ET | 200 | 258.25 |
12:09 ET | 200 | 257.92 |
12:12 ET | 900 | 258.5 |
12:14 ET | 300 | 258.67 |
12:16 ET | 200 | 258.545 |
12:18 ET | 800 | 258.47 |
12:20 ET | 100 | 258.46 |
12:21 ET | 100 | 258.505 |
12:23 ET | 1110 | 258.67 |
12:25 ET | 1800 | 259.3 |
12:27 ET | 217 | 259.07 |
12:30 ET | 600 | 259.4 |
12:32 ET | 100 | 259.385 |
12:34 ET | 200 | 259.47 |
12:36 ET | 500 | 259.625 |
12:39 ET | 400 | 259.37 |
12:41 ET | 3323 | 258.88 |
12:43 ET | 780 | 258.69 |
12:45 ET | 400 | 258.96 |
12:50 ET | 300 | 258.685 |
12:52 ET | 600 | 259.215 |
12:54 ET | 500 | 259.05 |
12:56 ET | 200 | 259.025 |
12:59 ET | 100 | 259.14 |
01:01 ET | 201 | 259.54 |
01:03 ET | 200 | 259.595 |
01:06 ET | 300 | 259.41 |
01:08 ET | 500 | 259.7 |
01:10 ET | 748 | 259.98 |
01:12 ET | 700 | 260.1 |
01:14 ET | 200 | 260.12 |
01:15 ET | 500 | 260.08 |
01:19 ET | 200 | 259.82 |
01:21 ET | 300 | 260.37 |
01:26 ET | 400 | 260.595 |
01:28 ET | 400 | 260.4 |
01:30 ET | 700 | 260.51 |
01:32 ET | 554 | 259.95 |
01:33 ET | 100 | 259.86 |
01:35 ET | 463 | 260.145 |
01:37 ET | 100 | 260.28 |
01:39 ET | 500 | 260.485 |
01:42 ET | 2459 | 260.31 |
01:44 ET | 300 | 260.13 |
01:46 ET | 1296 | 259.9 |
01:48 ET | 400 | 259.59 |
01:51 ET | 400 | 260.215 |
01:53 ET | 700 | 259.84 |
01:55 ET | 300 | 259.96 |
02:00 ET | 500 | 260.01 |
02:02 ET | 1097 | 260.26 |
02:04 ET | 100 | 260.265 |
02:06 ET | 100 | 260.445 |
02:08 ET | 1415 | 260.45 |
02:09 ET | 1011 | 260.2963 |
02:11 ET | 300 | 259.985 |
02:15 ET | 100 | 259.945 |
02:18 ET | 100 | 260.075 |
02:20 ET | 100 | 260.01 |
02:22 ET | 1100 | 260.305 |
02:24 ET | 967 | 260.35 |
02:26 ET | 322 | 260.395 |
02:27 ET | 300 | 260.615 |
02:31 ET | 1205 | 260.67 |
02:33 ET | 100 | 260.725 |
02:36 ET | 400 | 260.915 |
02:38 ET | 2011 | 260.63 |
02:40 ET | 210 | 260.54 |
02:42 ET | 300 | 260.485 |
02:45 ET | 1116 | 260.465 |
02:47 ET | 200 | 260.515 |
02:49 ET | 306 | 260.65 |
02:54 ET | 1137 | 260.735 |
02:56 ET | 2824 | 260.02 |
02:58 ET | 423 | 259.93 |
03:00 ET | 100 | 259.73 |
03:02 ET | 300 | 259.44 |
03:03 ET | 300 | 259.79 |
03:05 ET | 100 | 259.7239 |
03:07 ET | 1000 | 260.23 |
03:09 ET | 501 | 260.39 |
03:12 ET | 700 | 260.365 |
03:16 ET | 800 | 260.405 |
03:18 ET | 2001 | 259.78 |
03:20 ET | 301 | 259.88 |
03:23 ET | 101 | 259.935 |
03:25 ET | 200 | 260.05 |
03:27 ET | 1201 | 260.06 |
03:30 ET | 600 | 260.15 |
03:32 ET | 3000 | 259.93 |
03:34 ET | 100 | 259.94 |
03:36 ET | 724 | 260.015 |
03:38 ET | 100 | 260.16 |
03:39 ET | 1612 | 260.055 |
03:41 ET | 786 | 260.105 |
03:43 ET | 2543 | 260.3 |
03:45 ET | 1366 | 260.46 |
03:48 ET | 3707 | 260.46 |
03:50 ET | 1134 | 260.21 |
03:52 ET | 1628 | 260.39 |
03:54 ET | 1323 | 260.18 |
03:56 ET | 9632 | 260.42 |
03:57 ET | 3014 | 260.47 |
03:59 ET | 51328 | 260.51 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
United Therapeutics Corp | 11.6B | 12.3x | +8.22% |
Exact Sciences Corp | 11.6B | -55.8x | --- |
Medpace Holdings Inc | 12.4B | 40.8x | +35.10% |
Qiagen NV | 9.4B | 27.9x | +12.66% |
Biomarin Pharmaceutical Inc | 15.6B | 77.7x | --- |
Neurocrine Biosciences Inc | 14.3B | 38.9x | +62.04% |
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $11.6B |
---|---|
Revenue (TTM) | $2.5B |
Shares Outstanding | 44.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.47 |
EPS | $21.13 |
Book Value | $127.23 |
P/E Ratio | 12.3x |
Price/Sales (TTM) | 4.6 |
Price/Cash Flow (TTM) | 10.5x |
Operating Margin | 50.31% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.